Topic: How To Invest

Hi Pat: What are your thoughts on OraSure Technologies? Thanks.

Article Excerpt

A: OraSure Technologies, $15.07, symbol OSUR on Nasdaq (Shares outstanding: 58.4 million; Market cap: $880.1 million; www.orasure.com), manufactures HIV tests, Hepatitis C tests, substance abuse tests, freezing systems for removing warts, and genetic tests. The company has two business segments: OraSure contributes 75% of overall revenue; DNA Genotek accounts for 25%. OraSure’s HIV infectious disease tests contribute 38% of annual revenue, followed by molecular and genetic tests (25%), substance abuse tests (10%) and freezing systems (10%). Other sources of revenue (17%) include funding support from the Biomedical Advanced Research and Development Authority for OraSure’s work on a test for the Zika virus; the company is also paid by drug maker AbbVie to co-promote its OraQuick HCV (hepatitis C virus) test in the U.S. OraSure won approval March 1, 2017, from the Global Fund to supply the OraQuick HIV Self-Test in countries most affected by the infectious disease. The Fund is a partnership between governments and the private sector; it invests $4 billion annually…